INFLUENZA IMMUNIZATION

This study tested a new mRNA vaccine designed to protect against a potential pandemic flu caused by the H5 strain. A total of 276 healthy adults aged 18 and older received either a low, medium, or high dose of the vaccine or a placebo. The main goals were to check the vaccine's s…

This early-stage study tested a new mRNA-based flu vaccine in 233 healthy adults aged 18 and older. Researchers gave different doses to see if it was safe and how well it triggered an immune response. The goal is to develop a more effective flu vaccine using mRNA technology.

This study tested a single combination shot that aims to protect against both COVID-19 and influenza at the same time. About 980 adults aged 50 and older received either the combo vaccine, a flu shot alone, a COVID-19 shot alone, or both shots separately. Researchers monitored sa…

This study looked at whether adults aged 65 and older can safely get a high-dose flu vaccine and a Moderna COVID-19 booster at the same time. About 306 volunteers who had already received two doses of the Moderna COVID-19 vaccine took part. Researchers measured side effects and i…

This early-stage study tested a new mRNA-based flu vaccine in 159 healthy adults aged 18-49 and 60+. Participants received one injection of the experimental vaccine or a licensed flu shot. The main goals were to check safety and measure the immune response. Results will help deci…

This study tested a new combination vaccine that aims to protect against both COVID-19 and the flu with a single shot. About 980 adults aged 50 and older took part. Researchers checked how safe the vaccine was and how well it boosted the immune system compared to getting separate…

This study tested whether a high-dose flu vaccine works better than the standard dose for adults aged 60 and older. About 1,500 healthy volunteers received either the high-dose or standard-dose shot. Researchers measured immune responses 28 days later and tracked safety. The goal…

This study tested a new type of flu vaccine (RIV4) in over 1,300 people aged 9 to 49. The goal was to see if the vaccine works as well in children and teens (9-17) as it does in adults (18-49), and to check its safety. The vaccine aims to prevent flu by helping the body build imm…

This study tested a high-dose flu vaccine against a standard-dose one in 2,100 adults aged 60 and older in Japan. The goal was to see if the high-dose shot triggers a stronger immune response. Results showed the high-dose vaccine produced higher antibody levels, which may offer b…

This study collected blood samples from 90 healthy children (6 months to under 9 years) and adults 65 and older who received the 2020-2021 flu vaccine. The samples were taken before and after vaccination and sent to experts at the WHO, CDC, and FDA to help decide which flu strain…

This study surveyed about 5,000 adults in Germany to find out how many people got a flu shot during the current respiratory season. The goal was to get up-to-date information, especially for people aged 60 and older, to help health officials encourage more vaccinations. Participa…

This study asked over 1,000 adults in the U.S. about their experiences after receiving a trivalent recombinant influenza vaccine. Participants completed a 30-minute online survey about pain, anxiety, and any reactions they had. The goal was to understand how well the vaccine is t…

This study collected blood samples from 90 healthy children (6 months to under 9 years) and adults (65 and older) after they received their seasonal flu vaccine. The samples were sent to experts to help decide which flu strains to include in future vaccines. The study did not tes…